Ocean Historical Balance Sheet
| OCEA Stock | 0.06 0.01 11.25% |
Trend analysis of Ocean Biomedical balance sheet accounts such as Accounts Payable of 1.1 M provides information on Ocean Biomedical's total assets, liabilities, and equity, which is the actual value of Ocean Biomedical to its prevalent stockholders. By breaking down trends over time using Ocean Biomedical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Ocean Biomedical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Ocean Biomedical is a good buy for the upcoming year.
Ocean |
About Ocean Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Ocean Biomedical at a specified time, usually calculated after every quarter, six months, or one year. Ocean Biomedical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Ocean Biomedical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Ocean currently owns. An asset can also be divided into two categories, current and non-current.
Ocean Biomedical Balance Sheet Chart
Add Fundamental
Total Current Liabilities
Total Current Liabilities is an item on Ocean Biomedical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Ocean Biomedical are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Accounts Payable
An accounting item on the balance sheet that represents Ocean Biomedical obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Ocean Biomedical are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Most accounts from Ocean Biomedical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Ocean Biomedical current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocean Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Ocean Stock refer to our How to Trade Ocean Stock guide.At present, Ocean Biomedical's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 36.2 M, whereas Total Assets are forecasted to decline to about 6 M.
| 2022 | 2023 | 2024 | 2025 (projected) | Total Current Liabilities | 3.5M | 30.0M | 34.5M | 36.2M | Other Current Liabilities | 2.7M | 17.0M | 19.5M | 20.5M |
Ocean Biomedical balance sheet Correlations
Click cells to compare fundamentals
Ocean Biomedical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Ocean Biomedical balance sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 386K | 79K | 110.9M | 5.5M | 6.3M | 6.0M | |
| Other Current Liab | 2.2M | 212K | 2.7M | 17.0M | 19.5M | 20.5M | |
| Total Current Liabilities | 2.3M | 6.7M | 3.5M | 30.0M | 34.5M | 36.2M | |
| Total Stockholder Equity | (1.9M) | (6.7M) | 104.3M | (90.8M) | (81.7M) | (77.6M) | |
| Retained Earnings | (1.9M) | (64.2M) | (2.8M) | (196.1M) | (176.4M) | (167.6M) | |
| Accounts Payable | 53K | 34.4K | 324.8K | 933K | 1.1M | 1.1M | |
| Total Liab | 2.3M | 6.7M | 6.6M | 96.3M | 110.7M | 116.2M | |
| Net Invested Capital | (1.9M) | (6.7M) | 106.4M | (78.6M) | (70.8M) | (67.2M) | |
| Total Current Assets | 386K | 79K | 468.0K | 2.1M | 2.4M | 2.5M | |
| Net Working Capital | (1.9M) | (6.7M) | (3.0M) | (27.9M) | (25.1M) | (23.9M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocean Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Ocean Stock refer to our How to Trade Ocean Stock guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocean Biomedical. If investors know Ocean will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocean Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Ocean Biomedical is measured differently than its book value, which is the value of Ocean that is recorded on the company's balance sheet. Investors also form their own opinion of Ocean Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Ocean Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocean Biomedical's market value can be influenced by many factors that don't directly affect Ocean Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocean Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocean Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocean Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.